Oxidative stress: A cause and therapeutic target of diabetic complications

被引:140
作者
Araki, Eiichi [1 ]
Nishikawa, Takeshi [1 ]
机构
[1] Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan
基金
日本学术振兴会;
关键词
Adenosine monophosphate kinase; Mitochondria; Manganese superoxide dismutase; ALPHA-LIPOIC ACID; INTENSIVE INSULIN THERAPY; OXYGEN SPECIES PRODUCTION; 10-YEAR FOLLOW-UP; HYPERGLYCEMIA; ACTIVATION; PREVENTS; KIDNEY; TRIAL; GLYCOSYLATION;
D O I
10.1111/j.2040-1124.2010.00013.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Oxidative stress is defined as excessive production of reactive oxygen species (ROS) in the presence of diminished anti-oxidant substances. Increased oxidative stress could be one of the common pathogenic factors of diabetic complications. However, the mechanisms by which hyperglycemia increases oxidative stress are not fully understood. In this review, we focus on the impact of mitochondrial derived ROS (mtROS) on diabetic complications and suggest potential therapeutic approaches to suppress mtROS. It has been shown that hyperglycemia increases ROS production from mitochondrial electron transport chain and normalizing mitochondrial ROS ameliorates major pathways of hyperglycemic damage, such as activation of polyol pathway, activation of PKC and accumulation of advanced glycation end-products (AGE). Additionally, in subjects with type 2 diabetes, we found a positive correlation between HbA1c and urinary excretion of 8-hydroxydeoxyguanosine (8-OHdG), which reflects mitochondrial oxidative damage, and further reported that 8-OHdG was elevated in subjects with diabetic micro-and macro-vascular complications. We recently created vascular endothelial cell-specific manganese superoxide dismutase (MnSOD) transgenic mice, and clarified that overexpression of MnSOD in endothelium could prevent diabetic retinopathy in vivo. Furthermore, we found that metformin and pioglitazone, both of which have the ability to reduce diabetic vascular complications, could ameliorate hyperglycemia-induced mtROS production by the induction of PPAR gamma coactivator-1 alpha (PGC-1 alpha) and MnSOD and/or activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK). We also found that metformin and pioglitazone promote mitochondrial biogenesis through the same AMPK-PGC-1 alpha pathway. Taking these results, mtROS could be the key initiator of and a therapeutic target for diabetic vascular complications. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00013.x, 2010)
引用
收藏
页码:90 / 96
页数:7
相关论文
共 46 条
[1]
VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[2]
The sensory symptoms of diabetic polyneuropathy are improved with α-lipoic acid -: The SYDNEY trial [J].
Ametov, AS ;
Barinov, A ;
Dyck, PJ ;
Hermann, R ;
Kozlova, N ;
Litchy, WJ ;
Low, PA ;
Nehrdich, D ;
Novosadova, M ;
O'Brien, PC ;
Reljanovic, M ;
Samigullin, R ;
Schuette, K ;
Strokov, I ;
Tritschler, H ;
Wessel, K ;
Yakhno, N ;
Ziegler, D .
DIABETES CARE, 2003, 26 (03) :770-776
[3]
[Anonymous], LANCET
[4]
The free radical theory of aging matures [J].
Beckman, KB ;
Ames, BN .
PHYSIOLOGICAL REVIEWS, 1998, 78 (02) :547-581
[5]
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease [J].
Belch, Jill ;
MacCuish, Angus ;
Campbell, Iain ;
Cobbe, Stuart ;
Taylor, Roy ;
Prescott, Robin ;
Lee, Robert ;
Bancroft, Jean ;
MacEwan, Shirley ;
Shepherd, James ;
Macfarlane, Peter ;
Morris, Andrew ;
Jung, Roland ;
Kelly, Christopher ;
Connacher, Alan ;
Peden, Norman ;
Jamieson, Andrew ;
Matthews, David ;
Leese, Graeme ;
McKnight, John ;
O'Brien, Iain ;
Semple, Colin ;
Petrie, John ;
Gordon, Derek ;
Pringle, Stuart ;
MacWalter, Ron .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 :a1840
[6]
ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING [J].
BROWNLEE, M .
ANNUAL REVIEW OF MEDICINE, 1995, 46 :223-234
[7]
Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[8]
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].
Dormandy, JA ;
Charbonnel, B ;
Eckland, DJA ;
Erdmann, E ;
Massi-Benedetti, M ;
Kmoules, IK ;
Skene, AM ;
Tan, MH ;
Lefébvre, PJ ;
Murray, GD ;
Standl, E ;
Wilcox, RG ;
Wlhelmsen, L ;
Betteridge, J ;
Birkeland, K ;
Golay, A ;
Heine, RJ ;
Korányi, L ;
Laakso, M ;
Mokán, M ;
Norkus, A ;
Pirags, V ;
Podar, T ;
Scheen, A ;
Scherbaum, W ;
Schernthaner, G ;
Schmitz, O ;
Skrha, J ;
Smith, U ;
Taton, J .
LANCET, 2005, 366 (9493) :1279-1289
[9]
NERVE-CONDUCTION AND ALDOSE REDUCTASE INHIBITION DURING 5 YEARS OF DIABETES OR GALACTOSEMIA IN DOGS [J].
ENGERMAN, RL ;
KERN, TS ;
LARSON, ME .
DIABETOLOGIA, 1994, 37 (02) :141-144
[10]
Oxidative stress as a major culprit in kidney disease in diabetes [J].
Forbes, Josephine M. ;
Coughlan, Melinda T. ;
Cooper, Mark E. .
DIABETES, 2008, 57 (06) :1446-1454